Novo Nordisk and Anthropic announced a collaboration on September 16, 2026, under which the drugmaker will use Anthropic's frontier AI models and test the Claude Science workbench in specific research and development workflows, with the stated goal of accelerating the discovery and development of new medicines. Collaboration Scope and Governance In the announcement, datelined Bagsværd, Denmark, the companies said they will jointly address key drug discovery challenges identified by scientists…
This article has been indexed from Unite.AI
Read the original article: